Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-21-022341

10% owner bought 10,925 shares at $5.25 ($57,356)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cambrian BioPharma Inc 10% owner 2021-12-16 Purchase +10,925 $5.25 $57,356 4,823,169 D: show line 1 in the form
Open-market purchases · 10,925 sh · avg $5.25 · $57,356
Loading xslF345X03/doc1.xml…